| Selpercatinib studied in …STUDIED_INderived21 of 21show fewer |
|---|
| → studied in | NCT07822880Phase 4 · not yet recruiting A Study of Selpercatinib (LY3527723) in Participants With Rearranged During Transfection (RET)-Altered Cancers in India · 21 trials list this drug (17 active) | — | — | Thyroid Gland Neoplasm,Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04280081Phase 2 · active not recruiting A Study of Selpercatinib (LY3527723) in Participants With Advanced Solid Tumors Including RET Fusion-positive Solid Tumors, Medullary Thyroid Cancer and Other Tumors With RET Activation · 21 trials list this drug (17 active) | — | — | Solid Neoplasm,Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04320888Phase 2 · active not recruiting Selpercatinib for the Treatment of Advanced Solid Tumors, Lymphomas, or Histiocytic Disorders With Activating RET Gene Alterations, a Pediatric MATCH Treatment Trial · 21 trials list this drug (17 active) | — | — | Hematopoietic and Lymphatic System Neoplasm,Hepatoblastoma,Histiocytic and Dendritic Cell Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03155620Phase 2 · active not recruiting Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial) · 21 trials list this drug (17 active) | — | — | Hepatoblastoma,Malignant Germ Cell Tumor,Malignant Solid Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04759911Phase 2 · active not recruiting Selpercatinib Before Surgery for the Treatment of RET-Altered Thyroid Cancer · 21 trials list this drug (17 active) | — | — | Malignant Thyroid Gland Neoplasm,Thyroid Gland Anaplastic Carcinoma,Thyroid Gland Medullary Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07543887completed Selpercatinib and Body Composition · 21 trials list this drug (17 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03157128Phase 1/Phase 2 · active not recruiting A Study of Selpercatinib (LOXO-292) in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer (LIBRETTO-001) · 21 trials list this drug (17 active) | — | — | Lung Non-Small Cell Carcinoma,Thyroid Gland Medullary Carcinoma,Malignant Colon Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04268550Phase 2 · active not recruiting Targeted Treatment for RET Fusion-Positive Advanced Non-Small Cell Lung Cancer (A LUNG-MAP Treatment Trial) · 21 trials list this drug (17 active) | — | — | Malignant Lung Neoplasm,Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04211337Phase 3 · active not recruiting A Study of Selpercatinib (LY3527723) in Participants With RET-Mutant Medullary Thyroid Cancer · 21 trials list this drug (17 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04819100Phase 3 · active not recruiting A Study of Selpercatinib After Surgery or Radiation in Participants With Non-Small Cell Lung Cancer (NSCLC) · 21 trials list this drug (17 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07146893early Phase 1 · not yet recruiting Feasibility Study for Repurposing RET Inhibitors · 21 trials list this drug (17 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03899792Phase 1/Phase 2 · active not recruiting A Study of Oral LOXO-292 (Selpercatinib) in Pediatric Participants With Advanced Solid or Primary Central Nervous System (CNS) Tumors · 21 trials list this drug (17 active) | — | — | Soft Tissue Sarcoma,Myofibromatosis,Thyroid Gland Medullary Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04194944Phase 3 · active not recruiting A Study of Selpercatinib (LY3527723) in Participants With Advanced or Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer · 21 trials list this drug (17 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07010393Phase 4 · not yet recruiting Genotype-Driven Neoadjuvant Therapy for Locally Advanced Thyroid Cancer: A Real-World Cohort Study · 21 trials list this drug (17 active) | — | — | Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03944772Phase 2 · active not recruiting Phase 2 Platform Study in Patients With Advanced Non-Small Lung Cancer Who Progressed on First-Line Osimertinib Therapy (ORCHARD) · 21 trials list this drug (17 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03906331approved for marketing Expanded Access for the Treatment of Cancers With Rearranged During Transfection (RET) Activation · 21 trials list this drug (17 active) | — | — | Malignant Breast Neoplasm,Malignant Pancreatic Neoplasm,Lung Non-Small Cell Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05668962Phase 2 · recruiting Restor. I-131 Upt. + Selpercatinib in RET F-P RAI-R TC · 21 trials list this drug (17 active) | — | — | Thyroid Gland Follicular Carcinoma,Malignant Thyroid Gland Neoplasm,Thyroid Gland Carcinoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06532149recruiting ERectile Dysfunctions, gOnadotoxicity and Sexual Health Assessment in Men With Lung Cancer · 21 trials list this drug (17 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05364645Phase 2 · withdrawn Testing the Use of Targeted Treatment for RET Positive Advanced Non-small Cell Lung Cancer · 21 trials list this drug (17 active) | — | — | Malignant Lung Neoplasm,Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02925234Phase 2 · recruiting The Drug Rediscovery Protocol (DRUP Trial) · 21 trials list this drug (17 active) | — | — | Neoplasm,Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04591431Phase 2 · unknown The Rome Trial From Histology to Target: the Road to Personalize Target Therapy and Immunotherapy · 21 trials list this drug (17 active) | — | — | Malignant Breast Neoplasm,Malignant Digestive System Neoplasm,Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |